Strong association of chromosome 1p12 loci with thyroid cancer susceptibility

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 6, 2008, Pages 1499-1504

  Baida, Aida ^a,b   Akdi, Mounaim ^a   Lez Flores, Eddy Gonza ^a   Galofre, Pere ^c   Marcos, Ricard ^a,b   Zquez, Antonia Vela ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CHROMOSOME 1P; CONFIDENCE INTERVAL; ENVIRONMENTAL FACTOR; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; THYROID CANCER;

ADULT; ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SPAIN; THYROID NEOPLASMS;

EID: 53349154202     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0235     Document Type: Article

References (28)

1. Sherman SI. Thyroid carcinoma. Lancet 2003;361:501-11.
2. Hunt JL. Molecular mutations in thyroid carcinogenesis. Am J Clin Pathol 2002;118:S116-27.
3. Kondo T, Ezzat S, Asa Sl. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006;6:292-306.
4. Vecchio G, Santoro M. Oncogenes and thyroid cancer. Clin Chem Lab Med 2000;38:113-6.
5. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chernobyl. Nature 1992;359:21.
6. Inskip PD. Thyroid cancer after radiotherapy for childhood cancer. Med Pediatr Oncol 2001;36:568-73.
7. Hernàndez A, Cespedes W, Xamena N, et al. Glutathione S-transferase polymorphisms in thyroid cancer patients. Cancer Lett 2003;190:37-44.
8. Cybulski C, Gorski B, Huzarski T, et al. CHEK2 is a multi-organ cancer susceptibility gene. Am J Hum Genet 2004;75:1131-5.
9. Iuliano R, Le Pera I, Cristofaro C, et al. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis. Oncogene 2004;23:8432-8.
10. Matakidou A, Hamel N, Polpat S, et al. Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene. Carcinogenesis 2004;25:369-73.
11. Silva SN, Gil OM, Oliveira VC, et al. Association of polymorphisms in ERCC2 gene with non-familial thyroid cancer risk. Cancer Epidemiol Biomarkers Prev 2005;4:2407-12.
12. Lonn S, Bhatti P, Alexander BH, et al. Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of U.S. radiologic technologists. Cancer Epidemiol Biomarkers Prev 2007;6:174-7.
13. Baida A, Farrington SM, Galofré P, et al. Thyroid cancer susceptibility and THRA1 and BAT-40 repeats polymorphisms. Cancer Epidemiol Biomarkers Prev 2005;14:638-42.
14. Rudolph B, Harbott J, Lampert F. Fragile sites and neuroblastoma: fragile site at 1p13.1 and other points on lymphocyte chromosomes from patients and family members. Cancer Genet Cytogenet 1988;31:83-94.
15. Bieche I, Champeme MH, Matifas F, et al. Demonstration of two regions involved in chromosome 1p deletion in breast tumors. Bull Cancer 1994;81:108-13.
16. Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 1997;15:417-74.
17. Zhang J, Glatfelter AA, Taetle R, et al. Frequent alterations of evolutionarily conserved regions of chromosome 1 in human malignant melanoma. Cancer Genet Cytogenet 1999;111:119-23.
18. Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39:175-91.
19. Ardlie KG, Kruglyak L, Seielstad M. Patterns of linkage disequilibrium in the human genome. Nat Rev Genet 2002;3:299-309.
20. Van der Voorn L, Ploegh HL. The WD-40 repeat. FEBS Lett 1992;307: 131-134.
21. Smith TF, Gaitatzes C, Saxena K, et al. The WD repeat: a common architecture for diverse functions. Trends Biochem Sci 1999;245:181-5.
22. Chernova OB, Hunyadi A, Malaj E, et al. A novel member of the WD-repeat gene family, WDR11, maps to the 10q26 region and is disrupted by a chromosome translocation in human glioblastoma cells. Oncogene 2001;20:5378-92.
23. Honore B, Baandrup U, Nielsen S, et al. Endonuclein is a cell cycle regulated WD-repeat protein that is up-regulated in adenocarcinoma of the pancreas. Oncogene 2002;21:1123-9.
24. Proikas-Cezanne T, Waddell S, Gaugel A, et al. WIPI-1α (WIPI49), a member of the novel 7-bladed WIPI protein family, is aberrantly expressed in human cancer and is linked to starvation-induced autophagy. Oncogene 2004;23:9314-25.
25. Silva FP, Hamamoto R, Nakamura Y, et al. WDRPUH, a novel WD-repeat-containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferation. Neoplasia 2005;7:348-55.
26. Liu H, Nakagawa T, Kanematsu T, et al. Isolation of 10 differentially expressed cDNAs in differentiated Neuro2a cells induced through controlled expression of the GD3 synthase gene. J Neurochem 1999; 72:1781-90.
27. Begemann G, Gibert Y, Meyer A, et al. Cloning of zebrafish T-box genes tbx15 and tbx18 and their expression during embryonic development. Mech Dev 2002;114:137-41.
28. Singh MK, Petry M, Haenig B, et al. The T-box transcription factor Tbx15 is required for skeletal development. Mech Dev 2005;122:131-44.